Claritas Pharmaceuticals Inc V.CLAS

Primary Symbol: V.CLAS.H Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by rigpig99on Mar 04, 2021 1:46pm

121 Views

Post# 32716607

Hope you are right.

If you are new to this stock you should look at some of the history. GVHD miracle cure, patents and 600 million shares outstanding later. I sold out of this stock at 2 cents just before it stopped trading. Thought I was lucky until this recent run up but there were several run ups before it stopped trading as Kalyterra Therapeutics too. do your own DD just be cautious with this one. GLTA

<< Previous

Bullboard Posts

Next >>

New Canadian drone made exclusively for military operations